Background: Prolonged hospital lengths of stay increase costs, delay rehabilitation, and expose acute ischemic stroke patients to hospital-acquired infections. We designed and implemented a nurse-driven transitions of care coordinator (TOCC) program to facilitate the transition of care from the acute care hospital setting to rehabilitation centers and home.Methods: This was a single-blinded, prospective, randomized pilot study of 40 participants to evaluate the feasibility of implementing a TOCC program led by a stroke nurse navigator in hospitalized acute ischemic stroke patients. The intervention consisted of a stroke nurse navigator completing eight specific tasks, including meeting with stroke patients and their families, facilitating communication between team members at multi-disciplinary rounds, assisting with referrals to rehabilitation facilities, providing stroke education, and arranging stroke clinic follow-up appointments, which were confirmed to be completed by independent study personnel. The primary outcome was to assess the feasibility of the program. The secondary outcomes included comparing hospital length of stay (LOS) and patient satisfaction between the TOCC and usual care groups. We also explored the association between patient-level variables and LOS.Results: The TOCC program was feasible with all pre-specified components completed in 84.2% (95% CI: 60.4–96.6%) and was not significantly different from the assumed completion rate of 75% (p = 0.438). There was no significant difference in median LOS between the two groups [TOCC 5.95 days (4.02, 9.57) vs. usual care 4.01 days (2.00, 10.45), false discovery rate (FDR)-adjusted p = 0.138]. There was a trend toward higher patient median satisfaction in the TOCC group [TOCC 35.00 (33.00, 35.00) vs. usual care 30 (26.00, 35.00), FDR-adjusted p = 0.1] as assessed by a questionnaire at 30 days after discharge. The TOCC study allowed us to identify patient variables (gender, insurance, stroke severity, and discharge disposition) that were significantly associated with longer hospital LOS.Conclusion: A TOCC program is feasible and can serve as a guide for future allocation of resources to facilitate transitions of care and avoid prolonged hospital stays.
Introduction: Recurrent strokes carry a higher risk of disability and mortality than first-ever acute ischemic stroke (AIS). Several studies have demonstrated that controlling blood pressure (BP) reduces the risk of recurrent stroke. National guidelines suggest diuretics and ACE inhibitors (ACE-i) may be preferred for BP control in stroke survivors. Hypothesis: We hypothesized that there would be a wide variation in the classes of blood pressure medications prescribed to adult AIS patients at the time of hospital discharge. Methods: We reviewed 483 consecutive adult AIS patients admitted to our institution from January 2015 to April 2017. ICH, SAH and TIA patients were excluded. BP medications were categorized by type according to the Get with the Guidelines (GWTG) database. Hypertension was defined as a known past medical history of hypertension on admission. Exploratory and descriptive analyses were performed. Results: Baseline characteristics and discharge disposition are in shown in table 1. Of the 483 AIS patients, 373 (77.2%) had a known history of hypertension. Among the patients, 335 (90%) were prescribed BP medications at discharge, 135 (40%) received an ACE-i , 69 (21%) an angiotensin receptor blocker (ARB), 121 (36%) a diuretic, 182 (54%) a beta blocker, 134 (40%) a calcium channel blocker, and 10% other BP medications. Conclusions: There is wide variation in classes of BP medications prescribed at hospital discharge after AIS. Although ACE-i and diuretics are recommended in the AHA/ASA guidelines for BP treatment after AIS, they were not prescribed to the majority of AIS patients. Further studies are needed to evaluate in-hospital antihypertensive medication prescribing patterns in a national multi-center study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.